Better than Prozac: Creating the Next Generation of Psychiatric DrugsBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7419.875-a (Published 09 October 2003) Cite this as: BMJ 2003;327:875
- Sabina Dosani, specialist registrar in child and adolescent psychiatry (email@example.com)
- Maudsley Hospital, London
Prozac (fluoxetine) was once full of promise: a miracle cure for a miserable generation. Since its launch in 1989 more than 35 million people have been prescribed the drug. Peter Krammer's Listening to Prozac, which presented patients whose thoughts, personalities, and lives were transformed by the drug, was published in 1993 and became a best seller. A backlash followed. Prozac and other selective serotonin reuptake inhibitors (SSRIs) were described by some experts as addictive, while others …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial